Vivani Medical
VANI
22 hedge funds and large institutions have $1.28M invested in Vivani Medical in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 6 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
62% more capital invested
Capital invested by funds: $789K → $1.28M (+$493K)
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
10% more funds holding
Funds holding: 20 → 22 (+2)
0.37% less ownership
Funds ownership: 1.36% → 0.99% (-0.37%)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$324K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$50.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$45.8K |
| 4 |
Renaissance Technologies
New York
|
+$30.4K |
| 5 |
Jane Street
New York
|
+$25.3K |
Top Sellers
VANI Hedge Fund Activity: Q4 2020 in Review
22 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q4 2020, worth a combined $1.28M — up 62% from $789K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VANI positions and 6 closed out — a net gain of 2 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $324K. The largest seller was Versant Venture Management, exiting entirely with an estimated $484K sold.
- 22 institutional investors held Vivani Medical (VANI) as of Q4 2020, up from 20 in Q3 2020.
- Funds reported $1.28M of Vivani Medical stock for Q4 2020, up 62% quarter-over-quarter.
- 8 funds opened new Vivani Medical positions in Q4 2020 and 6 closed out, a net change of +2 holders.
- The largest Vivani Medical buyer in Q4 2020 was Vanguard Group, an estimated $324K added.
- The largest Vivani Medical seller in Q4 2020 was Versant Venture Management, an estimated $484K sold.
Based on aggregated 13F filings for Q4 2020.